FDA Inspection 1057149 — Mark V. DiBuono, MD

Mark V. DiBuono, MD — FEI 3007159391

The FDA completed an inspection of Mark V. DiBuono, MD on Jun 14, 2018 in Staten Island, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Staten Island, NY (United States)

Additional Details

Clinical Investigator (CI)